Equity - Incentive Equity Awards - Additional Information (Detail) - USD ($) $ in Thousands								6 Months Ended
		Jun. 27, 2022	May 16, 2022	Feb. 04, 2022	Jan. 10, 2022	Jun. 14, 2021	Jan. 04, 2021	Jun. 30, 2022	Jun. 30, 2021
Stockholders Equity Note [Line Items]
Stock Options Issued								25,247	810,459
Proceeds from exercise of stock options, net of transaction costs								$ 49	$ 2,134
Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Stock options, outstanding								19,995,396
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Shares issued, related to the vesting of RSUs								681,216	1,031,171
Treasury shares for settlement of employee tax obligations								222,634	398,214
Restricted Stock Units (RSUs) | Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Restricted stock units, outstanding								15,023,937
Percentage of outstanding shares on a fully diluted basis								3.00%
Stock units, Granted					81,082	218,000	3,265,700
Stock options, Granted			360,000
Stock units, Vesting Period			3 years		3 years	3 years	3 years
Restricted Stock Units (RSUs) | Employees | Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Stock units, Granted		661,459		5,987,500			1,345,800
Stock units, Vesting Period		3 years		3 years
Stock Options | Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Percentage of outstanding shares on a fully diluted basis								5.00%
Stock options, Granted			447,438		103,569	278,271	3,100,200
Stock units, Vesting Period				4 years			4 years
Stock units, Cliff Vesting Period							1 year
Stock Options | Employees | Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Stock options, Granted		817,873		1,976,600
Stock units, Cliff Vesting Period				1 year
Performance-Based RSUs
Stockholders Equity Note [Line Items]
Shares issued, related to the vesting of RSUs	[1]								1,762,244
Treasury shares for settlement of employee tax obligations									747,955
Performance-Based RSUs | Employees | Stock Incentive Plan 2020
Stockholders Equity Note [Line Items]
Stock units, Granted				1,089,500

[1] Performance-based RSUs vested in connection with the achievement of certain regulatory and sales performance conditions associated with the REDUCE-IT clinical trial and subsequent revenue growth. These performance-based RSUs have fully vested as of August 2021.